|
antidepressants: reboxetine a new option Dencker SJ Neuropsychiatry Unit, Institute of Clinical Neurosciences, Sahlgrenska University Hospital, Goteborg, Sweden. Acta Psychiatr Scand Suppl 2000; 402:6-11 ABSTRACT The selective serotonin reuptake inhibitors (SSRIs) have obtained global attention but have not demonstrated superior efficacy in major depression compared with older tricyclic antidepressants. From a pharmacological viewpoint the noradrenergic system in the brain appears to have a central role in neurotransmitter organization. The importance of noradrenaline in depression is supported by its association with clinical parameters such as vigilance and drive. Reboxetine is a selective noradrenaline reuptake inhibitor--the first in its class to be marketed. In both preclinical and clinical studies reboxetine has been found to be an effective and safe antidepressant. Furthermore, reboxetine restores a patients' social functioning producing a better quality of remission than fluoxetine.
Tianeptine | Moclobemide
|
Deprenyl
|
Picamilon | cataract
| stroke
| diabetes
|
Reboxetine research / abstracts
1. Reboxetine role in antidepressant therapy
2. Reboxetine efficacy and tolerability
3. Reboxetine clinical pharmacologic profile
4. Reboxetine Inhibiting noradrenaline and serotonin reuptake
5. Reboxetine and depression in the elderly
6. Reboxetine with severe major depressive disorder
7. Reboxetine clinical efficacy in major depression
8. Reboxetine tolerability and safety for major depression
9. Reboxetine comparison with fluoxetine
10. Reboxetine versus fluoxetine, impact on social functioning
11. Reboxetine versus fluoxetine, differential effects
12. Reboxetine prevents relapse in major depression
13. Reboxetine efficacy compared with imipramine
14. Noradrenaline reuptake inhibition
15. Antidepressants noradrenergic versus serotonergic
16. Reboxetine in the treatment of bulimia
17. Reboxetine hemodynamic effects in healthy males
18. Reboxetine effects of antidepressant therapy
19. Reboxetine place in antidepressant therapy
20. Reboxetine stimulant effects in patients with narcolepsy
21. Reboxetine selective noradrenaline reuptake inhibitor (NARI)Reboxetine manufacturer's product insert
